Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 9Pain 8Pain, Postoperative 5Breast Neoplasms 5Depression 4Agnosia 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain, Intractable 2Chronic Pain 2Acute Pain 2Prostatic Neoplasms 1Postoperative Analgesia 1Peripheral Nervous System Diseases 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Neurotoxicity Syndromes 1Neuralgia 1Mucositis 1Lymphoma, Follicular 1Lung Neoplasms 1Hypoxia 1Head and Neck Neoplasms 1Emergence Delirium 1Depressive Disorder, Major 1Colorectal Neoplasms 1Colonic Neoplasms 1Choledocholithiasis 1Choledochal Cyst 1Cholangitis 1Cancer Pain 1

Interventions

Tea 2Bupivacaine 2Tadalafil 1Supine Position 1Morphine 1Ketamine 1Injections, Subcutaneous 1Influenza Vaccines 1Head-Down Tilt 1Dexmedetomidine 1Anesthetics, Local 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Abdominal Cancer × Ketamine × Clear all
NCT02927379 2018-01-09

Effect of Wound Infiltration by Ketamine Versus Dexmedetomidine Added to Bupivacaine on Surgical Stress

Assiut University

Phase 3 Completed
90 enrolled

Abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡